← FDA Drug Approvals (Drugs@FDA)

DALFAMPRIDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2020-07-06

Drug application

FDA Application #

ANDA206858

Application type

Abbreviated New Drug Application (Generic)

Brand name

DALFAMPRIDINE

Generic name

Dalfampridine

Active ingredients

DALFAMPRIDINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

RISING

First approval

2020-07-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown